|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Nalpropion Pharmaceuticals
| | | Phone: | (800) 793-2145 | Year Established: | 2018 | Ticker: | PTX | Exchange: | NYSE | | Company Description | Nalpropion Pharmaceuticals is a newly formed special purpose entity capitalized by an investor group that includes Pernix Therapeutics Holdings, a specialty pharmaceutical company. Nalpropion was formed through an asset purchase agreement with Orexigen Therapeutics. | |
|
|
|
|
|